|
|
Incorporated in 1984, Makers Laboratories Limited is a Pharmaceutical Company that engages in the business of marketing Branded Generic Pharmaceutical Formulations such as Duramol (Paracetamol), Artemak-AB (α-β Arteether), Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffin (Anti cough Range) and Exylin (Amoxycillin range).
The company has a product range of 170 products in therapy segments such as Anti Malarials, Analgesics, Anti Pyretics, Anti-Allergy, Nutritional Supplements, Dermatology, Ophthalmic, Anti Diabetic, Anti-Hypertensives etc. Makers Laboratories has warehouses in Ahmedabad, Ambala, and Mumbai, which cater to Distributors across India.
The company operates on a PAN India basis with a strong distribution network of 20 Consignment Agents and 15 Super Stockiest, catering to more than 1500 Stockiest, 1,00,000 Doctors and 2,00,000 Retailers.
| Issue Open | Apr 18, 2022 - Apr 27, 2022 |
| Security Name | Makers Laboratories Limited |
| Issue Size (Shares) | 983,396 |
| Issue Size (Amount) | ₹14.75 Crores |
| Issue Price | ₹150 per share |
| Face Value | ₹10 per share |
| Listing At | BSE |
| Terms of Payment | Investors will have to pay the full amount of Rs 150 on the application. |
| Entitlement | 1 Rights Equity Shares for every 5 fully paid-up Equity Shares held on the Record Date |
| Record Date | Apr 1, 2022 |
| Credit of Rights Entitlements | Apr 11, 2022 |
| Bid/Offer Opens On | Apr 18, 2022 |
| Renunciation of Rights Entitlements | Apr 22, 2022 |
| Bid/Offer Closes On | Apr 27, 2022 |
| Deemed Date of Allotment | May 6, 2022 |
| Credit Date | May 9, 2022 |
| Listing Date | May 11, 2022 |
| Particulars | For the year/period ended (Rs in Lakhs) | ||||
|---|---|---|---|---|---|
| 31-Mar-21 | 31-Mar-20 | ||||
| Total Assets | 7,911.59 | 7,387.49 | |||
| Total Revenue | 4,482.54 | 5,162.21 | |||
| Profit After Tax | -161.66 | -12.38 | |||
The Company intends to utilize the Proceeds from the Issue towards funding of the following objects:
2 3.5 Rating:  Vote Here ... |
Makers Laboratories Limited
54-D,
Kandivli Industrial Estate,
Kandivli (W), Mumbai, 400067
Phone: 022-28688544
Email: investors@makerslabs.com
Website: https://www.makerslabs.com/
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: makerslab.rights@linkintime.co.in
Website: https://linkintime.co.in/
The Makers Laboratories Rights Issue 2022 opens on Apr 18, 2022, and closes on Apr 27, 2022.
Makers Laboratories Rights Issue 2022 Schedule
| Last Date for credit of Rights Entitlements | Apr 11, 2022 |
| Last Date for renunciation of Rights Entitlements | Apr 22, 2022 |
| Issue Opening Date | Apr 18, 2022 |
| Issue Closing Date | Apr 27, 2022 |
| Date of Allotment (on or about) | May 6, 2022 |
| Date of Credit (on or about) | May 9, 2022 |
| Date of Listing (on or about) | May 11, 2022 |
Makers Laboratories Rights Issue 2022 price is set at ₹150 per share per equity share.
The eligible shareholders are being offered 1 Rights Equity Shares for every 5 fully paid-up Equity Shares held on the Record Date (Apr 1, 2022).
The record date for the Makers Laboratories Rights Issue 2022 is Apr 1, 2022.
The issue size of Makers Laboratories Rights Issue 2022 is of 983,396 equity shares at ₹150 per share aggregating upto ₹14.75 Crores.
The Letter of Offer for Makers Laboratories Rights Issue 2022 can be download here.
You can apply for Makers Laboratories Rights Issue 2022 in two ways:
Steps to apply for Makers Laboratories Rights Issue 2022 using Net Banking (ASBA)
Note: Your bank may not offer this facility to certain rights issues. In that case, you may have to choose the option below.
Steps to apply for Makers Laboratories Rights Issue 2022 using Registrar's website (R-WAP)
FREE Account Opening (₹0)
FREE Intraday Trading (Eq, F&O)
30 days brokerage free trading
Free - Relationship Manager
Free - Classroom Training
|
|
